| |
| Issue |
Title |
| |
| No 11 (2022) |
Connective tissue and microbiota. The facets of interaction in norm and pathology |
Abstract
PDF (Rus)
|
|
E. I. Tkachenko, L. B. Lazebnik |
| |
| No 11 (2022) |
Medicinal-microbial interactions and ways of correcting iatrogenic intestinal dysbiosis |
Abstract
PDF (Rus)
|
|
I. G. Bakulin, M. Yu. Serkova |
| |
| No 11 (2022) |
Disturbance of intestinal permeability and its role in the development of cardiovascular complications in persons with inflammatory bowel diseases |
Abstract
PDF (Rus)
|
|
O. V. Khlynova, E. A. Stepina |
| |
| No 11 (2022) |
Features of assessing the intestinal barrier permeability in chronic kidney disease |
Abstract
PDF (Rus)
|
|
M. O. Pyatchenkov, A. A. Vlasov, E. V. Sherbakov, A. N. Belskykh, E. V. Kryukov, A. G. Markov |
| |
| No 11 (2022) |
Axis “microbiota - muscle” |
Abstract
PDF (Rus)
|
|
A. N. Zavyalova, V. P. Novikova, P. D. Ignatova |
| |
| No 11 (2022) |
Microbiome changes in acne patients with celiac disease under different treatments |
Abstract
PDF (Rus)
|
|
S. S. Ledentsova, N. I. Gulyaev, L. S. Oreshko, P. V. Seliverstov |
| |
| No 11 (2022) |
Microbiota of the small intestine in patients with COVID-19 |
Abstract
PDF (Rus)
|
|
Yu. S. Karpeeva, K. A. Klikunova, A. G. Platonova, E. V. Balukova |
| |
| No 11 (2022) |
The conjugacy of the use of synbiotic Maxilac® with the severity and duration of the course of COVID-19 in outpatient treatment |
Abstract
PDF (Rus)
|
|
O. V. Soldatova, I. Ya. Goryanskaya, E. A. Zaharyan, V. S. Ivanchenko |
| |
| 1 - 8 of 8 Items |
|
